Literature DB >> 19759138

Evolutionary dynamics of GII.4 noroviruses over a 34-year period.

Karin Bok1, Eugenio J Abente, Mauricio Realpe-Quintero, Tanaji Mitra, Stanislav V Sosnovtsev, Albert Z Kapikian, Kim Y Green.   

Abstract

Noroviruses are a major cause of epidemic gastroenteritis in children and adults, and GII.4 has been the predominant genotype since its first documented occurrence in 1987. This study examined the evolutionary dynamics of GII.4 noroviruses over more than three decades to investigate possible mechanisms by which these viruses have emerged to become predominant. Stool samples (n = 5,424) from children hospitalized at the Children's Hospital in Washington, DC, between 1974 and 1991 were screened for the presence of noroviruses by a custom multiplex real-time reverse transcription-PCR. The complete genome sequences of five GII.4 noroviruses (three of which predate 1987 by more than a decade) in this archival collection were determined and compared to the sequences of contemporary strains. Evolutionary analysis determined that the GII.4 VP1 capsid gene evolved at a rate of 4.3 x 10(-3) nucleotide substitutions/site/year. Only six sites in the VP1 capsid protein were found to evolve under positive selection, most of them located in the shell domain. No unique mutations were observed in or around the two histoblood group antigen (HBGA) binding sites in the P region, indicating that this site has been conserved since the 1970s. The VP1 proteins from the 1974 to 1977 noroviruses contained a unique sequence of four consecutive amino acids in the P2 region, which formed an exposed protrusion on the modeled capsid structure. This protrusion and other observed sequence variations did not affect the HBGA binding profiles of recombinant virus-like particles derived from representative 1974 and 1977 noroviruses compared with more recent noroviruses. Our analysis of archival GII.4 norovirus strains suggests that this genotype has been circulating for more than three decades and provides new ancestral strain sequences for the analysis of GII.4 evolution.

Entities:  

Mesh:

Year:  2009        PMID: 19759138      PMCID: PMC2772697          DOI: 10.1128/JVI.00864-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns.

Authors:  Pengwei Huang; Tibor Farkas; Séverine Marionneau; Weiming Zhong; Nathalie Ruvoën-Clouet; Ardythe L Morrow; Mekibib Altaye; Larry K Pickering; David S Newburg; Jacques LePendu; Xi Jiang
Journal:  J Infect Dis       Date:  2003-06-12       Impact factor: 5.226

2.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

3.  BLAST: at the core of a powerful and diverse set of sequence analysis tools.

Authors:  Scott McGinnis; Thomas L Madden
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Norwalk virus N-terminal nonstructural protein is associated with disassembly of the Golgi complex in transfected cells.

Authors:  Virneliz Fernandez-Vega; Stanislav V Sosnovtsev; Gaël Belliot; Adriene D King; Tanaji Mitra; Alexander Gorbalenya; Kim Y Green
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly.

Authors:  Kim Y Green; Gaël Belliot; Jean Lin Taylor; José Valdesuso; Judy F Lew; Albert Z Kapikian; Feng-Ying C Lin
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

6.  Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations.

Authors:  Søren Banke; Marie R Lillemark; Jan Gerstoft; Niels Obel; Louise B Jørgensen
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein.

Authors:  Andrea Bertolotti-Ciarlet; Sue E Crawford; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

Authors:  Ben Lopman; Harry Vennema; Evelyne Kohli; Pierre Pothier; Alicia Sanchez; Anabel Negredo; Javier Buesa; Eckart Schreier; Mark Reacher; David Brown; Jim Gray; Miren Iturriza; Chris Gallimore; Blenda Bottiger; Kjell-Olof Hedlund; Maria Torvén; Carl-Henrik von Bonsdorff; Leena Maunula; Mateja Poljsak-Prijatelj; Janet Zimsek; Gábor Reuter; György Szücs; Béla Melegh; Lennart Svennson; Yvonne van Duijnhoven; Marion Koopmans
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

9.  Mutation in a Lordsdale norovirus epidemic strain as a potential indicator of transmission routes.

Authors:  Kate E Dingle
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket.

Authors:  Ming Tan; Pengwei Huang; Jaroslaw Meller; Weiming Zhong; Tibor Farkas; Xi Jiang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more
  131 in total

1.  Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.

Authors:  Kazushi Motomura; Masaru Yokoyama; Hirotaka Ode; Hiromi Nakamura; Hiromi Mori; Tadahito Kanda; Tomoichiro Oka; Kazuhiko Katayama; Mamoru Noda; Tomoyuki Tanaka; Naokazu Takeda; Hironori Sato
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains.

Authors:  Martin Chi-Wai Chan; Nelson Lee; Wing-Shan Ho; Carmen Oi-Kwan Law; Terrence Chi-Kong Lau; Stephen Kwok-Wing Tsui; Joseph Jao-Yiu Sung
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus.

Authors:  Verónica Costantini; LaDonna Grenz; Angela Fritzinger; David Lewis; Christianne Biggs; Antony Hale; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

5.  Comparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.

Authors:  Liang Xue; Weicheng Cai; Qingping Wu; Xiaoxia Kou; Jumei Zhang; Weipeng Guo
Journal:  Virus Genes       Date:  2016-01-04       Impact factor: 2.332

6.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

7.  Evidence for recombination between pandemic GII.4 norovirus strains New Orleans 2009 and Sydney 2012.

Authors:  V Martella; M C Medici; S De Grazia; F Tummolo; A Calderaro; F Bonura; L Saporito; V Terio; C Catella; G Lanave; C Buonavoglia; G M Giammanco
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

8.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

9.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.